Explore therapeutic choices for patients with treatment-resistant depression, including ketamine, psilocybin, and various ...

The FDA has approved Flow, a prescription home-use cranial electrotherapy stimulation device, for treating moderate to severe ...

The FDA on Thursday approved a transcranial direct current stimulation (tDCS) device as the first at-home non-drug therapy for major depression in adults, maker Flow Neuroscience announced. Dubbed ...

The FDA recently cleared this device for sale in the U.S. Research shows it can improve moderate to severe depression symptoms in many people.

A small study shows cognitive improvements in patients with AD following treatment with an in-home gamma sensory stimulation ...

The US Food and Drug Administration (FDA) has cleared Flow Neuroscience’s at-home, non-drug depression treatment, making it the first device of its kind to gain clearance from the agency.

An in-home headset that allows people with depression to send mild electrical current to their brains has been cleared by the Food and Drug Administration, in what medical experts consider a milestone ...

As the holiday season kicks into full swing, global reports show that loneliness is on the rise despite the festiveness. Clinicians explain the reasons behind the paradox, how loneliness plays out in ...

FRIDAY, Dec. 12, 2025 (HealthDay News) — An at-home device that sends a gentle electrical current to the brain to help treat depression has been cleared by the U.S. Food and Drug Administration (FDA).

In a first, the US FDA has approved a device that allows you to treat depression at home. The headset delivers a mild electric current to the part of the brain that is known to regulate mood ...

Flow is a transcranial direct current stimulation device that delivers low-intensity direct electrical current to specific areas of the brain through electrodes that are placed on the scalp.